| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.33 | 0.0003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0006 |